RA Chem Pharma Limited

Our strength is in identifying, coordinating, developing and delivering APIs, Intermediates and Fine Chemicals to Companies Focused on niche market, niche products and custom synthesis from USA, Europe and Japan in tune with the new business strategies of the global pharmaceutical industry. From generics with custom specifications to orphan drugs, RA’s APIs services open out a new universe of business prospects.

The niche APIs operations are insulated in both directions from RA’s activities in intermediates and custom synthesis. This protects your market interests in formulations, whether generic or branded. RA’s APIs operations are built around a deep understand of IPR norms and regulatory protocols spanning all developed markets.

The RA paradigm opens avenues to sustain the breadth and depth of your competitiveness through a rare focus on stand-alone sale operating economics in niche APIs from the most regulated to the most volatile of market regions. RA’s competencies in complex chemistry, flexible manufacturing programmes, quick changeover capabilities, custom-quantity centered economics of scale and the acknowledged RA adherence to Quality, Cost-Effectiveness and Integration with your Production Planning Timelines (PPT) open out routes for greater competitiveness in the most challenging environments.